In Khyber-Pakhtunkhwa, Pakistan, the rising cost of essential medicines is causing alarm among patients and healthcare professionals. Notably, the price of insulin has surged from PKR 2,200 to PKR 4,720, more than doubling and placing a financial burden on diabetic patients reliant on this life-saving medication. Other common medicines have also seen significant price increases; for instance, a pack for indigestion has risen from PKR 530 to PKR 620, while thyroid medication has skyrocketed from PKR 85 to PKR 290, an increase of over 240%. These price hikes have been approved by regulatory authorities and are now in effect across pharmacies in Peshawar. Healthcare professionals warn that such steep increases could lead to patients skipping doses or opting for cheaper, potentially unsafe alternatives. Experts are urging the government to reconsider these price adjustments and implement subsidies or financial relief measures to alleviate the burden on low-income families and elderly patients, while also ensuring strict quality control to prevent the circulation of substandard medicines.